Human HCRT adenoviral particles

The hypocretin (HCRT) gene, also known as orexin, plays a crucial role in regulating the sleep-wake cycle, appetite, and neuroendocrine function. It encodes two neuropeptides: hypocretin-1 (orexin-A) and hypocretin-2 (orexin-B), which are primarily produced in the hypothalamus. These peptides bind to G protein-coupled receptors (HCRTR1 and HCRTR2) and are essential for maintaining wakefulness and preventing narcolepsy. Dysregulation of the HCRT system has been associated with sleep disorders, obesity, and neurodegenerative diseases. Due to its physiological significance, the HCRT gene has been extensively studied in neuroscience and metabolic research, making it an important target for gene therapy and functional studies.

Human HCRT Adenoviral Particles are recombinant viral vectors designed to deliver the HCRT gene to target cells for research or therapeutic applications. These particles are based on adenovirus, a highly efficient gene delivery system known for its ability to infect both dividing and non-dividing cells, including neurons. Adenoviral vectors are engineered to carry the human HCRT gene under the control of an appropriate promoter, ensuring its stable expression in transfected cells. These particles are widely used in preclinical studies to investigate the role of HCRT in sleep regulation, energy metabolism, and neurological disorders. In addition, they offer the potential for gene therapy for diseases such as narcolepsy, in which HCRT deficiency is a major pathological feature.